Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Greenwich LifeSciences, Inc. (GLSI) had Tangible Shareholders Equity of $1.44M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-4.03M |
|
-- |
|
-- |
|
$4.05M |
|
$-4.05M |
|
$0.02M |
|
$-4.03M |
|
$-4.03M |
|
$-4.03M |
|
$-4.03M |
|
$-4.03M |
|
$-4.03M |
|
$-4.05M |
|
$-4.05M |
|
13.37M |
|
13.37M |
|
$-0.30 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$3.13M |
|
-- |
|
-- |
|
$3.13M |
|
$1.69M |
|
-- |
|
-- |
|
$1.69M |
|
$1.44M |
|
|
Tangible Shareholders Equity |
$1.44M |
$1.44M |
|
13.47M |
|
| Cash Flow Statement Financials | |
$-4.07M |
|
-- |
|
$3.10M |
|
$4.09M |
|
$3.13M |
|
$-0.97M |
|
$3.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.85 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.07M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-279.63% |
|
-279.63% |
|
-128.80% |
|
-279.63% |
|
$0.11 |
|
$-0.30 |
|
$-0.30 |
|